CTOs on the Move


 
Founded in 1998, Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members of VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, Children’s Hospital Association, and Provista members used Novation contracts to purchase more than $43 billion in 2012.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Corner Home Medical

Corner Home Medical is a company that provides home medical equipment and supplies to patients and their families. They specialize in the treatment of patients with Obstructive Sleep Apnea (OSA), providing the largest selection of CPAP equipment and su...

Deutsches Altenheim

Deutsches Altenheim is a West Roxbury, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Physician`s Weekly

Physician`s Weekly (PW) is a leading source of trusted medical information, perspectives, and education for healthcare providers and patients. As pioneers in delivering medical information at the point of care, Physician`s Weekly supports over 39,000 top medical institutions and group practices across more than 20 specialties. By providing expert medical content through its print and digital products, Physician`s Weekly aims to improve the quality of communication between healthcare providers, their peers, patients, and caregivers.

Ovid Therapeutics

Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.

Current Medical Directions

Current Medical Directions is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.